Holista Colltech Limited ( (AU:HCT) ) just unveiled an update.
Holista Colltech Limited reported a significant reduction in net loss by 98% to $84K for FY2024, despite a 6% decline in revenue to $5.6M. The company achieved this through financial recoveries, cost-cutting measures, and strategic partnerships. New product launches, including SKNPRO Collagen and PROBIO-30, and the development of Nano Collagen for wound care, highlight Holista’s focus on innovation and market expansion. The company secured forward orders and is exploring the commercial potential of its patented Nano Collagen, indicating a positive outlook for future growth.
More about Holista Colltech Limited
Holista Colltech Limited operates in the health and wellness industry, focusing on dietary supplements, food ingredients, and infection control products. The company is known for its collagen-based products and is actively exploring new market opportunities, particularly in the development of Nano Collagen for wound care.
YTD Price Performance: 200.0%
Average Trading Volume: 276,648
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$8.57M
See more insights into HCT stock on TipRanks’ Stock Analysis page.